questionsmedicales.fr
Système nerveux
Système nerveux central
Encéphale
Tronc cérébral
Rhombencéphale
Métencéphale
Cervelet
Cervelet : Questions médicales fréquentes
Termes MeSH sélectionnés :
Disruptive, Impulse Control, and Conduct Disorders
Diagnostic
5
Cervelet
Dysfonction cérébelleuse
Imagerie par résonance magnétique
Tomodensitométrie
Ataxie
Troubles de la coordination
Ataxie héréditaire
Maladies génétiques
Équilibre
Tests neurologiques
Symptômes
5
Lésion cérébelleuse
Ataxie
Ataxie
Troubles de la coordination
Tremblement intentionnel
Cervelet
Prévention
5
Prévention
Mode de vie sain
Traumatisme crânien
Cervelet
Vaccins
Infections cérébrales
Alcoolisme
Dommages cérébelleux
Conseil génétique
Maladies héréditaires
Traitements
5
Réhabilitation
Thérapie physique
Chirurgie cérébrale
Tumeurs cérébelleuses
Médicaments
Symptômes cérébelleux
Médecine alternative
Thérapies complémentaires
Complications
5
Complications
Lésion cérébelleuse
Qualité de vie
Troubles du mouvement
Troubles cognitifs
Cervelet
Réhabilitation
Complications
Facteurs de risque
5
Facteurs de risque
Traumatismes crâniens
Âge
Dégénérescence cérébrale
Maladies auto-immunes
Inflammation cérébrale
Stress
Troubles cérébelleux
Infections
Lésion cérébelleuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cervelet : Questions médicales les plus fréquentes",
"headline": "Cervelet : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cervelet : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cervelet"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métencéphale",
"url": "https://questionsmedicales.fr/mesh/D020540",
"about": {
"@type": "MedicalCondition",
"name": "Métencéphale",
"code": {
"@type": "MedicalCode",
"code": "D020540",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.810.428"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cortex cérébelleux",
"alternateName": "Cerebellar Cortex",
"url": "https://questionsmedicales.fr/mesh/D002525",
"about": {
"@type": "MedicalCondition",
"name": "Cortex cérébelleux",
"code": {
"@type": "MedicalCode",
"code": "D002525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.810.428.200.212"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vermis cérébelleux",
"alternateName": "Cerebellar Vermis",
"url": "https://questionsmedicales.fr/mesh/D065814",
"about": {
"@type": "MedicalCondition",
"name": "Vermis cérébelleux",
"code": {
"@type": "MedicalCode",
"code": "D065814",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.810.428.200.212.299"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Noyaux du cervelet",
"alternateName": "Cerebellar Nuclei",
"url": "https://questionsmedicales.fr/mesh/D002529",
"about": {
"@type": "MedicalCondition",
"name": "Noyaux du cervelet",
"code": {
"@type": "MedicalCode",
"code": "D002529",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.810.428.200.337"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Angle pontocérébelleux",
"alternateName": "Cerebellopontine Angle",
"url": "https://questionsmedicales.fr/mesh/D002530",
"about": {
"@type": "MedicalCondition",
"name": "Angle pontocérébelleux",
"code": {
"@type": "MedicalCode",
"code": "D002530",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.810.428.200.462"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cervelet",
"alternateName": "Cerebellum",
"code": {
"@type": "MedicalCode",
"code": "D002531",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mario Manto",
"url": "https://questionsmedicales.fr/author/Mario%20Manto",
"affiliation": {
"@type": "Organization",
"name": "Unité Des Ataxies Cérébelleuses, CHU-Charleroi, Lodelinsart, Charleroi, Belgium. mario.manto@ulb.be."
}
},
{
"@type": "Person",
"name": "Michael Adamaszek",
"url": "https://questionsmedicales.fr/author/Michael%20Adamaszek",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical and Cognitive Neurorehabilitation, Klinik Bavaria Kreischa, Kreischa, Germany. michael.adamaszek@freenet.de."
}
},
{
"@type": "Person",
"name": "Hiroshi Mitoma",
"url": "https://questionsmedicales.fr/author/Hiroshi%20Mitoma",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Education, Tokyo Medical University, Tokyo 160-0023, Japan."
}
},
{
"@type": "Person",
"name": "Frank Van Overwalle",
"url": "https://questionsmedicales.fr/author/Frank%20Van%20Overwalle",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Psychology and Center for Neuroscience, Vrije Universiteit Brussel, 1050, Brussels, Belgium."
}
},
{
"@type": "Person",
"name": "Jeremy D Schmahmann",
"url": "https://questionsmedicales.fr/author/Jeremy%20D%20Schmahmann",
"affiliation": {
"@type": "Organization",
"name": "Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA 02114, United States. Electronic address: jschmahmann@mgh.harvard.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36370093",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/add.16086"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic prediction of impulse control disorders in Parkinson's disease.",
"datePublished": "2022-06-27",
"url": "https://questionsmedicales.fr/article/35762106",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acn3.51569"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Dopaminergic Therapy on Impulse Control Disorders in Patients With a Prolactinoma.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36149404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WNN.0000000000000320"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/36125673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11154-022-09753-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "APOE contributes to longitudinal impulse control disorders progression in Parkinson's disease.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334114",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-024-06084-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tronc cérébral",
"item": "https://questionsmedicales.fr/mesh/D001933"
},
{
"@type": "ListItem",
"position": 6,
"name": "Rhombencéphale",
"item": "https://questionsmedicales.fr/mesh/D012249"
},
{
"@type": "ListItem",
"position": 7,
"name": "Métencéphale",
"item": "https://questionsmedicales.fr/mesh/D020540"
},
{
"@type": "ListItem",
"position": 8,
"name": "Cervelet",
"item": "https://questionsmedicales.fr/mesh/D002531"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cervelet - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cervelet",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cervelet",
"description": "Comment diagnostiquer une dysfonction du cervelet ?\nQuels tests d'imagerie sont utilisés pour le cervelet ?\nQuels signes cliniques indiquent une atteinte du cervelet ?\nLe cervelet peut-il être affecté par des maladies génétiques ?\nComment évaluer l'équilibre d'un patient ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cervelet",
"description": "Quels sont les symptômes d'une lésion cérébelleuse ?\nComment se manifeste l'ataxie cérébelleuse ?\nLes troubles de la parole sont-ils liés au cervelet ?\nQu'est-ce que le tremblement intentionnel ?\nLes vertiges peuvent-ils être causés par des problèmes au cervelet ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cervelet",
"description": "Comment prévenir les troubles du cervelet ?\nLes accidents peuvent-ils affecter le cervelet ?\nY a-t-il des vaccins pour prévenir les infections cérébelleuses ?\nL'alcool peut-il nuire au cervelet ?\nComment éviter les maladies génétiques affectant le cervelet ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cervelet",
"description": "Quels traitements existent pour les troubles du cervelet ?\nLa chirurgie est-elle une option pour les tumeurs cérébelleuses ?\nLes médicaments peuvent-ils aider les symptômes cérébelleux ?\nComment la rééducation aide-t-elle les patients cérébelleux ?\nLes thérapies alternatives sont-elles efficaces pour le cervelet ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cervelet",
"description": "Quelles complications peuvent survenir après une lésion cérébelleuse ?\nLes troubles du cervelet peuvent-ils affecter la vie quotidienne ?\nLes patients cérébelleux risquent-ils des chutes ?\nLes troubles cognitifs peuvent-ils être liés au cervelet ?\nLes complications peuvent-elles être réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cervelet",
"description": "Quels sont les facteurs de risque pour les troubles du cervelet ?\nL'âge influence-t-il les troubles du cervelet ?\nLes maladies auto-immunes affectent-elles le cervelet ?\nLe stress peut-il affecter le cervelet ?\nLes infections peuvent-elles endommager le cervelet ?",
"url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Disruptive,+Impulse+Control,+and+Conduct+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction du cervelet ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique, des tests d'équilibre et des imageries cérébrales sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés pour le cervelet ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et le scanner sont couramment utilisés pour visualiser le cervelet."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte du cervelet ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de l'équilibre, des mouvements saccadés et des difficultés de coordination."
}
},
{
"@type": "Question",
"name": "Le cervelet peut-il être affecté par des maladies génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines ataxies héréditaires affectent le cervelet et sa fonction."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'équilibre d'un patient ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme le Romberg et le test de marche sur ligne droite sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion cérébelleuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ataxie, tremblements, vertiges et troubles de la parole peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'ataxie cérébelleuse ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des mouvements désordonnés et une perte d'équilibre."
}
},
{
"@type": "Question",
"name": "Les troubles de la parole sont-ils liés au cervelet ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés d'élocution peuvent résulter d'une dysfonction cérébelleuse."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le tremblement intentionnel ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un tremblement qui se produit lors de mouvements volontaires, souvent lié au cervelet."
}
},
{
"@type": "Question",
"name": "Les vertiges peuvent-ils être causés par des problèmes au cervelet ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cérébelleux peuvent entraîner des sensations de vertige."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles du cervelet ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, l'exercice régulier et l'évitement des toxines peuvent aider."
}
},
{
"@type": "Question",
"name": "Les accidents peuvent-ils affecter le cervelet ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent causer des lésions au cervelet."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir les infections cérébelleuses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins contre certaines infections comme la méningite peuvent aider à prévenir."
}
},
{
"@type": "Question",
"name": "L'alcool peut-il nuire au cervelet ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation excessive d'alcool peut entraîner des dommages au cervelet."
}
},
{
"@type": "Question",
"name": "Comment éviter les maladies génétiques affectant le cervelet ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique peut aider à évaluer les risques pour les familles concernées."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles du cervelet ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation, la thérapie physique et parfois des médicaments sont utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour les tumeurs cérébelleuses ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être nécessaire pour retirer des tumeurs au cervelet."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider les symptômes cérébelleux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent soulager les symptômes, mais ne guérissent pas la cause."
}
},
{
"@type": "Question",
"name": "Comment la rééducation aide-t-elle les patients cérébelleux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle améliore la coordination, l'équilibre et la fonction motrice par des exercices ciblés."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces pour le cervelet ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider, mais les preuves sont limitées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une lésion cérébelleuse ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de l'équilibre, des chutes fréquentes et des difficultés de coordination."
}
},
{
"@type": "Question",
"name": "Les troubles du cervelet peuvent-ils affecter la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent rendre les activités quotidiennes difficiles, comme marcher ou écrire."
}
},
{
"@type": "Question",
"name": "Les patients cérébelleux risquent-ils des chutes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de l'instabilité et des problèmes d'équilibre, le risque de chutes augmente."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs peuvent-ils être liés au cervelet ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines dysfonctions cérébelleuses peuvent entraîner des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent s'améliorer avec un traitement approprié et une rééducation."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles du cervelet ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'alcoolisme et les traumatismes crâniens sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les troubles du cervelet ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles cérébelleux augmente avec l'âge en raison de la dégénérescence."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes affectent-elles le cervelet ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes peuvent provoquer des inflammations cérébelleuses."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le cervelet ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut exacerber les symptômes des troubles cérébelleux."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles endommager le cervelet ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales ou bactériennes peuvent causer des lésions cérébelleuses."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
8 publications dans cette catégorie
Affiliations :
Unité Des Ataxies Cérébelleuses, CHU-Charleroi, Lodelinsart, Charleroi, Belgium. mario.manto@ulb.be.
Service Des Neurosciences, University of Mons, Mons, Belgium. mario.manto@ulb.be.
4 publications dans cette catégorie
Affiliations :
Department of Clinical and Cognitive Neurorehabilitation, Klinik Bavaria Kreischa, Kreischa, Germany. michael.adamaszek@freenet.de.
Publications dans "Cervelet" :
4 publications dans cette catégorie
Affiliations :
Department of Medical Education, Tokyo Medical University, Tokyo 160-0023, Japan.
Publications dans "Cervelet" :
4 publications dans cette catégorie
Affiliations :
Faculty of Psychology and Center for Neuroscience, Vrije Universiteit Brussel, 1050, Brussels, Belgium.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA 02114, United States. Electronic address: jschmahmann@mgh.harvard.edu.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Experimental Psychology, Helmholtz Institute, Utrecht University, Utrecht, The Netherlands. d.j.l.g.schutter@uu.nl.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Department of Neuroscience, Erasmus MC, Rotterdam, Netherlands.
Netherlands Institute for Neuroscience, Royal Dutch Academy of Arts & Sciences, Amsterdam, Netherlands.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Faculty of Psychology and Center for Neuroscience, Vrije Universiteit Brussel, 1050, Brussels, Belgium.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Columbia University Medical Center, New York, NY, 10032, USA.
Initiative of Columbia Ataxia and Tremor, Columbia University Medical Center, New York, NY, 10032, USA.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Ataxia Laboratory, Santa Lucia Foundation IRCCS, Rome, Italy.
Psychology Department, Sapienza University, Rome, Italy.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
Ataxia Laboratory, Santa Lucia Foundation IRCCS, Rome, Italy.
Psychology Department, Sapienza University, Rome, Italy.
Publications dans "Cervelet" :
3 publications dans cette catégorie
Affiliations :
National Institute of Neurological Disorders & Stroke, National Institutes of Health, Bethesda, Maryland 20814.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Milano-Bicocca, Milan, Italy.
IRCCS Mondino Foundation, Pavia, Italy.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA. Electronic address: stren021@umn.edu.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Área de Psicobiología, Universitat Jaume I, Castellón de la Plana, Spain.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Área de Psicobiología, Universitat Jaume I, Castellón de la Plana, Spain.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Münster, Münster, Germany. everss@uni-muenster.de.
Department of Neurology, Krankenhaus Lindenbrunn, Coppenbrügge, Germany. everss@uni-muenster.de.
Publications dans "Cervelet" :
2 publications dans cette catégorie
Affiliations :
Pharmacy El Toro, La Fuente 11, 12429 El Toro, Castellon, Spain. Electronic address: moreno210189@hotmail.com.
Publications dans "Cervelet" :
Impulse control disorders (ICDs) are iatrogenic and idiopathic conditions with psychosocial and economic consequences for the affected individuals and their families (e.g. bankruptcy and divorce). How...
To contextualize the ICD diagnostic construct, we provided an overview of its origins in past centuries and followed its development across multiple editions of the Diagnostic and Statistical Manual a...
Two independent roots of the ICD construct emerged: (a) the interest in behavioral excess as expressed in encyclopedic compilations (18th century) and (b) the juridical debate on disruptive conduct an...
The reasons that made impulse control disorders (ICDs) difficult to define from their first conceptualization are the same reasons that now complicate taxonomic efforts and diagnosis. Tracing back ICD...
To develop a clinico-genetic predictor of impulse control disorder (ICD) risk in Parkinson's disease (PD)....
In 5770 individuals from three PD cohorts (the 23andMe, Inc.; the University of Pennsylvania [UPenn]; and the Parkinson's Progression Markers Initiative [PPMI]), we used a discovery-replication strate...
By GWAS, we discovered four new loci associated with ICD at p-values of 4.9e-07 to 1.3e-06...
In this multi-cohort, international study, we developed an easily computed clinico-genetic tool, the ICD-RS, that substantially enriches for subgroups of PD at very high versus very low risk for ICD, ...
Studies have reported an increase in the incidence of impulse control disorders (ICDs) in patient groups treated with dopamine agonists (DAAs), especially in Parkinson disease (PD). However, very few ...
To see whether a DAA by itself causes ICDs in individuals with a prolactinoma by controlling the susceptibility to impulsivity by excluding individuals with other risk factors for ICDs....
We compared the performance of 31 individuals with a prolactinoma receiving DAA therapy (DAA+) on various behavioral scales and the Iowa gambling task (IGT), a neuropsychological instrument that measu...
There was no significant difference among the groups concerning performance on the Zuckerman Sensation Seeking Scale-V, Minnesota Impulse Disorders Interview, Barratt Impulsiveness Scale-11, or IGT. N...
Individuals who are under treatment with low-dose, D 2 -selective DAAs for a prolactinoma do not face an increased risk for ICDs, especially when they are carefully screened for any psychiatric comorb...
Dopamine agonists (DAs) represent a mainstay of therapy for hyperprolactinemia and prolactinomas. The widespread use of DAs, including bromocriptine, cabergoline and (in some countries) quinagolide, h...
Impulse control disorders (ICDs) are an increasingly recognized complication in Parkinson disease (PD). The pathogenesis of ICDs is currently unclear. Few genetic studies have been conducted in this a...
We aimed to ascertain the correlation between APOE and ICDs, and identify clinical predictors of ICDs in PD....
This study included 287 PD patients from the Parkinson's Progression Markers Initiative. They were followed up to investigate the progression of ICDs over a period of 5 years. The cumulative incidence...
44.3% (31/70) patients with APOE ɛ4 and 32.3% (70/217) patients without APOE ɛ4 developed ICDs during the five-year follow up period. There were significant differences between the PD with and without...
This study provides important insights into the potential role of the APOE gene in the development of ICDs in PD. Further studies are needed to confirm our findings and to investigate the underlying m...
This study was undertaken to evaluate whether the feedback-related negativity (FRN)-a neurophysiological marker of incentive processing-can be used to predict the development of impulse control disord...
The longitudinal cohort consisted of consecutive nondemented PD patients with no ICD history. We recorded FRN signals while they performed a gambling task. We calculated the mean amplitude difference ...
Between October 7, 2015 and December 16, 2016, we screened 120 patients. Among them, 94 patients performed the gambling and 92 completed the follow-up. Eighteen patients developed ICDs during follow-u...
Reward-processing differences measured by FRN signals precede ICD development in PD. This neurophysiological marker permits identification of patients with high risk of ICD development. ANN NEUROL 202...
Impulse control disorders (ICDs) in Parkinson's disease (PD) are increasingly recognized as clinically significant non-motor features that potentially impair the quality of life. White matter hyperint...
Some patients with Parkinson's disease (PD) experience impulse control disorders (ICDs), characterized by deficient voluntary control over impulses, drives, or temptations regarding excessive hedonic ...
Impulse control disorders (e.g. pathological gambling, hypersexuality) may develop as adverse reactions to drugs. Pathogenetic hypotheses have mainly focused on D3-receptor agonism, and switching to a...
We aimed to identify targets potentially contributing to pathologic impulsivity....
We performed a pharmacovigilance-pharmacodynamic study on dopamine agonists and antipsychotics using the Food and Drug Administration Adverse Event Reporting System (January 2004-December 2021). We es...
Among 19 887 reports of impulsivity, 5898 recorded an antipsychotic, and 3100 a dopamine agonist. The more robust signals concerned aripiprazole (N = 3091; median information component [95% confidence...
Our results supported the role of D3-receptor agonism in inducing impulsivity in dopamine receptor agonists and identified a potential role of 5-HT1a receptor agonism in antipsychotics. Investigating ...
The impact of non-motor symptoms is often overlooked in favour of the motor symptoms when managing Parkinson's disease resulting in suboptimal patient outcomes. This study aimed to characterise the no...